MoneyWorks4Me

The revenue zoomed 7.64% to Rs. 412.16 millions for the quarter ended September 2024 as compared to Rs. 382.89 millions during the corresponding quarter last year.The company has announced a 31.14% increase in its profits to Rs . 96.02  millions for the  quarter ended September 2024 compared to Rs. 73.22 millions in the corresponding quarter in the previous year.Operating Profit saw a handsome growth to 132.79 millions from 102.00 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 412.16 382.89 7.64 737.52 674.64 9.32 1419.66 1367.49 3.82
Other Income 18.53 10.96 69.07 32.59 21.33 52.79 46.67 51.23 -8.90
PBIDT 132.79 102.00 30.19 239.73 182.04 31.69 377.85 354.90 6.47
Interest 1.16 0.69 68.12 2.31 1.43 61.54 2.71 3.67 -26.16
PBDT 131.63 101.31 29.93 237.42 180.61 31.45 375.14 351.23 6.81
Depreciation 6.39 5.91 8.12 11.58 10.91 6.14 23.40 22.59 3.59
PBT 125.24 95.40 31.28 225.84 169.70 33.08 351.74 328.64 7.03
TAX 29.22 22.18 31.74 55.67 42.79 30.10 91.98 82.58 11.38
Deferred Tax -0.78 -3.48 -77.59 0.67 -2.89 -123.18 -5.21 -2.25 131.56
PAT 96.02 73.22 31.14 170.17 126.91 34.09 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 32.22 26.64 20.94 32.50 26.98 20.46 26.62 25.95 2.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..